FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers

Several chromosomal regions are found to be consistently amplified in human breast cancers. For two of these regions, 8p 12 and 10q26, we previously reported the amplification of genes encoding FGF receptors, FGFR1/FLG and FGFR2/BEK, in about 12% of breast tumors. The PLAT gene, encoding the tissue‐type plasminogen activator, is also located close to or within the 8p 12 region. In the present study, we show that both FGFR1 and PLAT can be amplified in breast as well as ovarian carcinomas. FGFR1 amplification was detected in 14.5% of breast and 7.8% of ovarian tumors, whereas PLAT was found to be amplified in 15.6% and 19.4% of the tumors, respectively. Each gene could be amplified independently of the other. These data raised the question of which gene is selected for amplification at 8p 12. In most cases, the levels of expression of FGFR1 and PLAT in breast tumors were comparable to their level of expression in normal mammary tissue. However, FGFR1 was expressed above the normal level in a certain number of cases. This gene could be a good candidate as “driver” of the 8p 12 amplification, but it cannot account for all complex molecular events taking place in this region. © 1993 Wiley‐Liss, Inc.

[1]  A. Tulpule,et al.  Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. O’Brien,et al.  BEK, a receptor for multiple members of the fibroblast growth factor (FGF) family, maps to human chromosome 10q25.3----q26. , 1992, Cytogenetics and cell genetics.

[3]  M. Herlyn,et al.  Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. , 1992, Oncogene.

[4]  M. Duffy,et al.  Multiple forms of plasminogen activator in human breast tumors. , 1985, Cancer research.

[5]  A. Saxena,et al.  Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. , 1992, Oncogene.

[6]  D. Birnbaum,et al.  BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.

[7]  D. Birnbaum,et al.  Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. , 1989, Oncogene.

[8]  D. Schwartz,et al.  Consistent Chromosome Abnormalities in Squamous Cell Carcinoma of the Vulva , 1991, Genes, chromosomes & cancer.

[9]  G. Peters,et al.  Chromosome 11q13 abnormalities in human cancer. , 1991, Cancer cells.

[10]  D. Birnbaum,et al.  BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. , 1991, Oncogene.

[11]  R. Lidereau,et al.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Schwab,et al.  Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines , 1992, Genes, chromosomes & cancer.

[13]  G. V. Vande Woude,et al.  Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Belin,et al.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. , 1987, Cancer research.

[15]  G. Wahl,et al.  Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. , 1992, Mutation research.

[16]  L. Sobin,et al.  Histological Typing of Breast Tumors 1 , 1982 .

[17]  M. Schmitt,et al.  UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCER , 1989, The Lancet.

[18]  D. Birnbaum,et al.  Characterization of a murine glyceraldehyde-3-phosphate dehydrogenase pseudogene. , 1990, Biochimie.

[19]  D. Gallwitz,et al.  Structure of two human beta‐actin‐related processed genes one of which is located next to a simple repetitive sequence. , 1983, The EMBO journal.

[20]  D. Birnbaum,et al.  Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. , 1989, Oncogene.

[21]  P. Goodfellow,et al.  A human sequence homologous to v-sea maps to chromosome 11, band q13. , 1988, Oncogene.

[22]  Teruhiko Yoshida,et al.  K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Takahashi,et al.  Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum‐free medium , 1989, International journal of cancer.

[24]  U. Bergerheim,et al.  Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma , 1991, Genes, chromosomes & cancer.

[25]  R. Coombes,et al.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. , 1992, British Journal of Cancer.

[26]  R. Zeillinger,et al.  HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. , 1989, Oncogene.

[27]  D. Birnbaum,et al.  The FGF-related oncogenes hst and int.2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21. , 1988, Oncogene.

[28]  D. Birnbaum,et al.  DNA amplification at 11q13 in human cancer: from complexity to perplexity. , 1992, Mutation research.

[29]  D. Birnbaum,et al.  Fusion and amplification of two originally non‐syntenic chromosomal regions in a mammary carcinoma cell line , 1992, Genes, chromosomes & cancer.

[30]  M. Jaye,et al.  Cloning and expression of two distinct high‐affinity receptors cross‐reacting with acidic and basic fibroblast growth factors. , 1990, The EMBO journal.

[31]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[32]  F. Alt,et al.  Human N-myc is closely related in organization and nucleotide sequence to c-myc , 1986, Nature.

[33]  D. Rifkin,et al.  Cell-associated plasminogen activation: regulation and physiological functions. , 1988, Annual review of cell biology.

[34]  M. Duffy,et al.  Urokinase plasminogen activator and prognosis in breast cancer , 1990, The Lancet.

[35]  B. Hecquet,et al.  [FGFB binding sites in cancers of the human breast]. , 1992, Bulletin du cancer.